We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
InterDigital
IDCC
$8.64B
| $14.4M | 0.03% |
64,034
+329
| +0.5% | +$69.7K |
|
502
ConocoPhillips
COP
$156B
| $14.1M | 0.03% |
157,665
-81,331
| -34% | -$7.32M |
|
503
CarGurus
CARG
$3.24B
| $14M | 0.03% |
417,801
+7,597
| +2% | +$229K |
|
504
Lumen
LUMN
$6.33B
| $14M | 0.03% |
3,186,562
+1,286,085
| +68% | +$4.98M |
|
505
Forte Biosciences
FBRX
$1.63B
| $13.9M | 0.03% |
+1,072,233
| New | +$9.23M |
|
506
Nu Holdings
NU
$71.9B
| $13.8M | 0.03% |
1,006,366
-207,617
| -17% | -$2.49M |
|
507
PPG Industries
PPG
$25.2B
| $13.8M | 0.03% |
121,050
-176,125
| -59% | -$19M |
|
508
Alcoa
AA
$13.5B
| $13.8M | 0.03% |
465,971
+12,401
| +3% | +$335K |
|
509
Vertiv
VRT
$104B
| $13.6M | 0.03% |
106,119
-1,016,917
| -91% | -$98.9M |
|
510
W.W. Grainger
GWW
$62.2B
| $13.6M | 0.03% |
13,030
+4,910
| +60% | +$5.1M |
|
511
Life Time Group Holdings
LTH
$9.91B
| $13.5M | 0.03% |
446,044
+121,664
| +38% | +$3.61M |
|
512
AMN Healthcare
AMN
$1.36B
| $13.5M | 0.03% |
651,409
+491,454
| +307% | +$10.2M |
|
513
Methode Electronics
MEI
$631M
| $13.5M | 0.03% |
1,414,441
+629
| +0% | +$4.62K |
|
514
Otter Tail
OTTR
$3.85B
| $13.2M | 0.02% |
171,526
-9,914
| -5% | -$774K |
|
515
Cboe Global Markets
CBOE
$32.8B
| $13.2M | 0.02% |
56,551
-2,079
| -4% | -$463K |
|
516
Astera Labs
ALAB
$52.8B
| $13.1M | 0.02% |
145,000
| – | – |
|
517
Byline Bancorp
BY
$1.73B
| $13.1M | 0.02% |
488,237
+2,084
| +0.4% | +$53.5K |
|
518
Owens Corning
OC
$11.4B
| $12.9M | 0.02% |
94,112
-1,753
| -2% | -$242K |
|
519
Bath & Body Works
BBWI
$3.76B
| $12.9M | 0.02% |
430,024
+405,158
| +1,629% | +$11.9M |
|
520
Sprinklr
CXM
$1.86B
| $12.8M | 0.02% |
1,510,162
-164,001
| -10% | -$1.31M |
|
521
Yext
YEXT
$678M
| $12.7M | 0.02% |
1,489,397
-938,537
| -39% | -$6.58M |
|
522
AvePoint
AVPT
$3.03B
| $12.6M | 0.02% |
654,772
-252,162
| -28% | -$4.37M |
|
523
Trustmark
TRMK
$2.68B
| $12.5M | 0.02% |
343,945
+2,018
| +0.6% | +$69.1K |
|
524
SAP
SAP
$255B
| $12.5M | 0.02% |
41,070
-11,057
| -21% | -$3.17M |
|
525
SiriusPoint
SPNT
$2.8B
| $12.3M | 0.02% |
600,985
+186,493
| +45% | +$3.43M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.